FindMyKOL
Clinical trialNCT06348134RecruitingPhase 2Interventional

Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery

SponsorUniversity of ChicagoEnrollment74Breast CancerHER2-positive Breast CancerHuman Epidermal Growth Factor 2 Negative Carcinoma of Breast
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Doctors leading this study would like to learn about providing cancer treatment/therapies to Nigerian women with breast cancer based on their human epidermal growth factor receptor 2 (HER2) status. This study will focus on the efficacy and safety of anti-HER2 cancer treatment before and after surgery.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Nigeria
  • Lagos State University Teaching Hospital

    Ikeja, Lagos, Nigeria

    ABIODUN POPOOLA
    Recruiting
  • Lagos University Teaching Hospital

    Yaba, Lagos, Nigeria

    ANTHONIA SOWUNMI
    Recruiting
  • Obafemi Awolowo University Teaching Hospitals Complex (oauthc)

    Ile-Ife, Osun State, Nigeria

    Recruiting
  • University of Ibadan Hospital

    Ibadan, Oyo State, Nigeria

    ATARA NTEKIM
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Docetaxel →Goserelin →Letrozole →Pertuzumab →Tamoxifen →Trastuzumab →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
18 Mar 2025
Primary completion
1 Jul 2034
Completion
1 Jul 2036
Last update posted
17 Feb 2026
Registered enrollment
74
Registry id
NCT06348134
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.